rethinkTHC Search
Menu
Study breakdown

Systematic Review Finds Limited Evidence for CHS Treatments, With Dopamine Antagonists Showing More Promise Than Capsaicin

Systematic ReviewModerate evidence
The takeaway

A systematic review of ED treatments for cannabinoid hyperemesis syndrome found mixed evidence for topical capsaicin across 5 studies but potentially beneficial results for dopamine antagonists (haloperidol, droperidol) in both available studies.

Emergency physicians, gastroenterologists, hospital pharmacists

Dopamine antagonists showed benefit in both studies; capsaicin results were mixed

What the researchers found

Of 7 included studies (5 observational, 2 RCTs; 492 total patients), 5 evaluated capsaicin cream (n=386) with mixed results, and 2 evaluated dopamine antagonists (n=106) with both detecting clinical benefit compared to usual care. Evidence for capsaicin was inconsistent for reducing nausea and emesis.

Why it matters

CHS is increasingly common in EDs, but evidence-based treatment guidelines are limited. This review provides the most comprehensive assessment of the two most-discussed ED interventions.

The numbers in context

7 studies; 492 total patients; 5 capsaicin studies (n=386, mixed results); 2 dopamine antagonist studies (n=106, both positive); 2 RCTs included.

How the study worked

Systematic review per PRISMA guidelines addressing a PICO question: adults with acute CHS in the ED, treated with dopamine antagonists or topical capsaicin vs. usual care. 53 articles screened, 7 included.

What this study cannot tell us

Small number of studies. Small patient numbers. Lack of standardized treatment protocols across studies. Risk of bias in observational studies.

How to read the evidence

Systematic review with limited included studies (7), small patient numbers, and mixed study quality.

When this study was published

2024 publication

The bigger picture

Emergency physicians currently manage CHS without strong evidence for any specific treatment. The slightly stronger signal for dopamine antagonists compared to capsaicin may shift clinical practice, though both need larger trials.

Questions still open

  • Would a large multicenter RCT comparing capsaicin, dopamine antagonists, and usual care settle the treatment question?
  • Are there other pharmacological approaches worth testing for CHS?

Common questions

How is CHS treated in the emergency room?
This systematic review evaluated two common approaches. Topical capsaicin cream had mixed results across 5 studies. Dopamine antagonists (haloperidol, droperidol) showed benefit in both studies that tested them, though the evidence remains limited.
Does capsaicin cream work for CHS?
Evidence is mixed. Of 5 studies evaluating topical capsaicin for CHS in the ED (386 patients total), results were inconsistent. Dopamine antagonists showed more consistent benefit in the 2 studies that tested them, though more research is needed for both treatments.

Read the original research

SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 31(5), 493-503

Citation

Sabbineni, Monica; Scott, William; Punia, Kiran; Manuja, Kriti; Singh, Angad; Campbell, Kaitryn; MacKillop, James; Balodis, Iris. (2024). SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 31(5), 493-503. https://doi.org/10.1111/acem.14770

Explore the wider topic